Boston Scientific (BSX) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 16.91% |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.95% |
| Mar 31, 2026 | -80.85% |
| Dec 31, 2025 | -66.05% |
| Sep 30, 2025 | 29.83% |
| Jun 30, 2025 | -72.87% |
| Mar 31, 2025 | 14.81% |
| Dec 31, 2024 | 172.77% |
| Sep 30, 2024 | -11.63% |
| Jun 30, 2024 | -8.03% |
| Mar 31, 2024 | 15.19% |
| Dec 31, 2023 | 57.58% |
| Sep 30, 2023 | 84.78% |
| Jun 30, 2023 | 11.10% |
| Mar 31, 2023 | 408.45% |
| Dec 31, 2022 | 203.59% |
| Sep 30, 2022 | 26.28% |
| Jun 30, 2022 | 116.95% |
| Mar 31, 2022 | -62.98% |
| Dec 31, 2021 | 297.24% |
| Sep 30, 2021 | 288.78% |